Code Red for Children: Austrian State Media Decries Paediatric Emergencies while Vaxx-Giddy Experts Perform their Loyalty to Big Pharma

Nothing new under the sun as the Unholy Trinity of legacy media gaslighting, expert shilling, and loyalty oaths are returning with a vengeance this Christmas season

While trying to catch up here, today’s piece contains a piece of Austrian state media on the current emergency in the health care sector, followed, as usual, by a few bottom lines; as always, emphases mine.

Some Paediatricians at the Limits of Capacity

Influenza, CoV, classical cold viruses and, above all, respiratory syncytial virus (RSV): the simultaneous and particularly strong occurrence of several viruses is currently pushing paediatric wards and physicians in hospitals to their limits. This is exacerbated by the acute shortage of paediatricians and supply shortages with respect to medications.

Viennese paediatrician Peter Voitl emphasises to ORF that what is currently happening in his and other paediatricians’ practices is ‘unbelievable’. ‘Countless children’ are currently coming into the practice, and because the paediatric wards in hospitals are also at their limits, many children ‘can currently only be treated as outpatients. But they actually need appropriate treatment and monitoring in the hospital’, he adds.

According to Voitl, the situation is exacerbated by the ‘acute shortage of paediatricians’ that has been going on for some time. Paediatricians could probably work around the clock at the moment, and they wouldn’t run out of work: Voitl points out that they are currently doing a lot of overtime. His group practice is also open on weekends, in addition to the three practices for weekend service. Only if one already works at least partially on Saturday and Sunday, one can manage the Monday at-all right now, says Voitl.

Limits, Despite a Seven-Day Workweek

But he emphasises that even with seven-day opening one reaches limits at some point. For example, he is currently unable to give appointments to some of his longstanding clients. And a rapid end to the triple wave of RSV, Influenza and Covid is not in sight.

The situation is currently similar throughout Austria: school classes and kindergarten groups are decimated, the waiting rooms in hospital outpatient departments and at paediatricians’ practices are overcrowded. With some delay, the RS virus has now also fully arrived in Carinthia; in Vorarlberg, the situation can currently still be managed.

Children’s Wards Are Full

In Vienna, the children’s wards in hospitals are already at full capacity. In Floridsdorf, according to inquiries at the Vienna Health Association [Gesundheitsverbund, the state-directed management company], there were just two free beds on Monday [5 Dec.], while children are constantly being discharged, mostly after five to ten days. Also, the paediatric wards of the hospital in Favoriten is full, and it looks quite similar in the AKH [Allgemeines Krankenhaus, Vienna General Hospital]. In the Donaustadt clinic, the number of children with RSV has fallen from 27 to 17 within a week—but at the same time, there are several children who have to be treated as inpatients for Influenza and Covid.

Drugs Partly Not Available

Voitl points to another problem that even further exacerbates the situation, namely, the limited availability of medications. Specifically, among other things, a certain cortisone-containing inhalation solution for children suffering from the RS virus is simply not available at the moment [isn’t that odd, I mean, corticosteroids are lacking after some 3 years of respiratory infections running amok…]. According to the Chamber of Pharmacists, this is due to supply chain problems that have existed since the Covid pandemic. Many drugs are produced in Asia. The current wave of viruses then further exacerbated the situation.

No End in Sight

Voitl is convinced that the RSV wave will continue until Christmas. This year it will be ‘very severe and very early’. In addition, Covid and Influenza, which has also been epidemic in Austria since last week, are occurring at the same time. Normally, the peak of the RSV wave is in January after the Christmas vacations, when many families return home from skiing.

Because there has been little viral activity in the last two years due to the lockdowns, RSV appeared early last year—in September—and this year is also too early compared to the long-term average.

Parallel Infections Possible

Voitl appeals to people to get vaccinated against influenza [while mentioning nothing about cross-immunity or viral interference, he fails to make the case as to why that would help against RSV or Covid]. This is because parallel infections—and thus illness from contracting both RSV and influenza—are also possible [I’ll have something to say about this in the bottom lines]. He has already had several such cases in his practice. Karl Zwiauer, head of the Department of Paediatrics and Adolescent Medicine at St. Pölten University Hospital and member of the National Immunisation Consortium [Nationales Impfgremium, NIG], also recommends influenza vaccination.

RSV can also become life-threatening, especially for babies up to one year of age. Therapeutically, there are few options, according to Voitl, the most important being the administration of oxygen. In somewhat older children, from the age of three, an RSV infection is usually not so bad. Treatment of the symptoms is sufficient, and then it is usually over after about a week. In the event of pain, high fever, or shortness of breath, you should see a doctor quickly, Voitl recommends.

For premature babies and children with chronic diseases, there is a medication that is administered as a preventive measure. And the paediatrician emphasises: Even though the symptoms are very similar in all three infections, specialists can usually recognize an RSV infection by a typical whistling sound when infants breathe.

---

Bottom Lines

I think of the most important things we’ve not talked about nearly enough in the past three years, the interrelated issues of viral interference and cross-immunity stand out.

This is particularly absurd, as we’ve seen the inflated threat of a ‘twin-demic’ (of Covid and Influenza), or ‘Flurona’, appearing as early as last winter, including the real menace of mandated joint Covid+Flu Shots (irrespective of either’s efficacy, to say nothing about their safety).

Is the addition of ‘buyer beware’ something you’d consider important in regards to these flu shots that, over the past decade, boasted at best 50% efficacy and which might contain mercury as an adjuvant?

Apart from that, the most notorious lie by omission—and failure to read up on literature on part of ‘The Experts™’ appears to be the issue of viral interference, or the ‘prevalence of co-infection’. Here, a quick glance at an o.k. study by Meskill and colleagues (Am J Emerg Med, doi: 10.1016/j.ajem.2016.12.001) would have surely helped. Entitled, ‘Prevalence of co-infection between respiratory syncytial virus and influenza in children’, this is where the money is. Or isn’t, upon reading:

Objective: To determine the prevalence of co-infection of RSV and influenza compared to the prevalence of those infections independently when both are in season.

This is a retrospective cross-sectional study, based on 13,664 specimens collected between 2010-13 that were subjected to ‘multiplex PCR’ testing. Quite right on the target, I’d say.

Results: 13,664 specimens were sent for PCR during the study period. Over all 3 seasons, RSV overlapped with influenza A and B for 22 and 18 weeks, respectively; in 2011-12, RSV overlapped with neither influenza A nor B. Based on modeling, there were 6-7 fold fewer cases of RSV/influenza co-infection observed than expected: RSV/influenza A 77 vs. 12, (p≤0.001; RSV/influenza B 76 vs. 11 (p≤0.001).

Conclusions: The observed incidence of co-infectivity of RSV and influenza was significantly less than the expected incidence even when both were co-circulating. In light of these data, it may be reasonable to forgo rapid influenza testing or empiric antiviral treatment for children whom rapid RSV testing is positive and who are at low risk of influenza-related complications, especially in times of antiviral therapy shortages.

Huhum.

Apart from that, the final point today is Dr. Zwiauer’s comment. I’ve come across that name a while ago, and for background, you may ‘enjoy’ (in a twisted sense) his affiliations with the nexus that ties together tropical and infectious disease expertise-national expertdom-social democratic politics. In short: Dr. Zwiauer belongs to a cabal of ‘experts’ with incredibly close ties to both Big Pharma, sits on said National Immunisation Consortium, and published frequently with all the other likeminded infectious disease ‘experts’ singing from the government’s playbook. Find out more about it here:

Covid in Austria: 'Experts' Recommend 4th Jab for all 12 and older, because: science. I'm kidding: Dr. Kollaritsch: 'I trust the Pfizer Covid vaccine. They developed Viagra.'

In another piece that appeared on 5 Dec. in Austrian state media, he’s quoted as follows about the paediatric emergencies (my emphases; if you spot more than three intellectual and logical fallacies, please mention them in the comments):

‘It’s really the case that the hygiene measures we’ve justifiably taken over the last two winters have meant that we now have a population that has had little to no exposure to these infections’, Zwiauer said [fallacy #1: lockdowns work, but they don’t]

‘With the lower mask requirement and hygiene measures, we now have a large pool of susceptible children, especially young children, at first contacts.’ As a result, the RSV wave is ‘particularly severe’ in terms of the number of cases, but the cases of illness are not more severe because of that, the paediatrician emphasises [at least he’s consistent in not making sense].

The paediatrician recommends vaccination, and while there is none against RSV yet—it is pending approval—but ‘now is the time to vaccinate and protect children against influenza. We are at the beginning of a wave’, Zwiauer said. Influenza vaccinations are available free of charge beginning at six months of age and without an injection in the form of nasal sprays beginning at age two. Abstinence from other vaccinations is not necessary, the paediatrician explains [fallacy #2: all medical interventions may come with cross-reactivity, esp. hitherto untested EUA-induced ‘other injections’ interacting with a bunch of other drugs; this reeks of malpractice].

In the RSV vaccine approval process, ‘the final clinical trial phases’ are underway, says Zwiauer, who is also a member of the National Immunisation Consortium. He said it is expected ‘that we will have the vaccine available within a year’. [what a joyous next Christmas this will bring]

Children can receive the coronavirus vaccine starting at six months of age. For at-risk children, ‘there is an active recommendation, those children should be vaccinated urgently’, Zwiauer said. ‘For all other children, there is no urgent recommendation, but the option is there. The urgency will be assessed on an individual basis, in terms of disease severity and risk.’ [fallacy #3: no urgency, eh, but an ‘option’ that ‘will be assessed on an individual basis’—are you telling me, Dr. Zwiauer, that any paediatrician will tell me, perhaps, don’t do it? What about, say, my kids with natural immunity: would there be any benefit to take these injections? (don’t worry, my kids won’t take that crap)]

I’ll stop here, for Dr. Zwiauer is a notorious Big Pharma shill, and as final visual proof, I’ll offer the below screen shot from a webinar he presented at in spring of this year, courtesy of the good people over at tkp.at; for an English-language version, please go here.

Brought to you by Pfizer. Also, Dr. Zwiauer, of course, declares ‘no conflicts of interests’, even though his presentations, lectures, and training sessions are ‘partially supported by firms, partially by honorariums‘